Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: July 25, 2017
What are the generic drug sources for celecoxib and what is the scope of celecoxib patent protection?
Celecoxib is the generic ingredient in two branded drugs marketed by Alembic Pharms Ltd, Aurobindo Pharma Ltd, Lupin Ltd, Cipla Ltd, Mylan Pharms Inc, Jubilant Generics, Watson Labs Inc, Torrent Pharms Ltd, Macleods Pharms Ltd, Apotex Inc, Gd Searle, and Teva, and is included in twelve NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.| Tradenames: | 2 |
| Patents: | 1 |
| Applicants: | 12 |
| NDAs: | 12 |
| Drug Master File Entries: see list | 25 |
| Suppliers / Packagers: see list | 51 |
| Bulk Api Vendors: see list | 86 |
| Clinical Trials: see list | 402 |
| Patent Applications: see list | 6,224 |
| Therapeutic Class: | Anti-inflammatory Agents |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see low prices |
| DailyMed Link: | celecoxib at DailyMed |
| Ingredient-type | Nonsteroidal Anti-inflammatory Compounds |
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Pharms Inc | CELECOXIB | celecoxib | CAPSULE;ORAL | 078857-002 | Feb 11, 2015 | AB | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Alembic Pharms Ltd | CELECOXIB | celecoxib | CAPSULE;ORAL | 204519-002 | Aug 21, 2015 | AB | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Macleods Pharms Ltd | CELECOXIB | celecoxib | CAPSULE;ORAL | 204590-002 | Mar 16, 2016 | AB | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Torrent Pharms Ltd | CELECOXIB | celecoxib | CAPSULE;ORAL | 207677-003 | Dec 23, 2015 | AB | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Teva | CELECOXIB | celecoxib | CAPSULE;ORAL | 076898-004 | May 30, 2014 | AB | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gd Searle | CELEBREX | celecoxib | CAPSULE;ORAL | 020998-001 | Dec 31, 1998 | ► Subscribe | ► Subscribe | ||||||||||||||||||||||
Gd Searle | CELEBREX | celecoxib | CAPSULE;ORAL | 020998-003 | Aug 29, 2002 | ► Subscribe | ► Subscribe | ||||||||||||||||||||||
Gd Searle | CELEBREX | celecoxib | CAPSULE;ORAL | 020998-002 | Dec 31, 1998 | ► Subscribe | ► Subscribe | ||||||||||||||||||||||
Gd Searle | CELEBREX | celecoxib | CAPSULE;ORAL | 020998-004 | Dec 15, 2006 | ► Subscribe | ► Subscribe | ||||||||||||||||||||||
Gd Searle | CELEBREX | celecoxib | CAPSULE;ORAL | 020998-003 | Aug 29, 2002 | ► Subscribe | ► Subscribe | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,132 others who get our Drug Patent Expiration Alerts:
